Literature DB >> 16167889

Functions of granulocyte-macrophage colony-stimulating factor.

Andrew J Fleetwood1, Andrew D Cook, John A Hamilton.   

Abstract

GM-CSF was originally defined by its ability to generate in vitro granulocyte and macrophage colonies from bone marrow precursor cells. Apart from its physiological role in the control of alveolar macrophage development, it now appears more likely that its major role lies in its ability to govern the properties of the more mature myeloid cells of the granulocyte and macrophage lineages, particularly during host defence and inflammatory reactions. Recent evidence is summarized below for a key role for GM-CSF in inflammatory and autoimmune diseases, making it therefore worthy of consideration for targeting. Such evidence includes disease exacerbation following its administration and amelioration of disease in animal models by GM-CSF gene targeting or by anti-GM-CSF antibody blockade. This review summarizes the evidence supporting a major role for GM-CSF in inflammation and autoimmunity and its functions as major regulator governing granulocyte and macrophage lineage populations at all stages of maturation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16167889     DOI: 10.1615/critrevimmunol.v25.i5.50

Source DB:  PubMed          Journal:  Crit Rev Immunol        ISSN: 1040-8401            Impact factor:   2.214


  91 in total

1.  Impaired pulmonary immunity post-bone marrow transplant.

Authors:  Stephanie M Coomes; Leah L N Hubbard; Bethany B Moore
Journal:  Immunol Res       Date:  2011-05       Impact factor: 2.829

2.  HIV-1-infected peripheral blood mononuclear cells enhance neutrophil survival and HLA-DR expression via increased production of GM-CSF: implications for HIV-1 infection.

Authors:  Jun Fu; Beverly E Sha; Larry L Thomas
Journal:  J Acquir Immune Defic Syndr       Date:  2011-01-01       Impact factor: 3.731

3.  Lipoxin A4 counterregulates GM-CSF signaling in eosinophilic granulocytes.

Authors:  Vitaliy Starosta; Konrad Pazdrak; Istvan Boldogh; Tetyana Svider; Alexander Kurosky
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

4.  High-dose but not low-dose mainstream cigarette smoke suppresses allergic airway inflammation by inhibiting T cell function.

Authors:  Thomas H Thatcher; Randi P Benson; Richard P Phipps; Patricia J Sime
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-06-20       Impact factor: 5.464

5.  GM-CSF produced by nonhematopoietic cells is required for early epithelial cell proliferation and repair of injured colonic mucosa.

Authors:  Laia Egea; Christopher S McAllister; Omar Lakhdari; Ivelina Minev; Steve Shenouda; Martin F Kagnoff
Journal:  J Immunol       Date:  2013-01-16       Impact factor: 5.422

Review 6.  Common and Novel Markers for Measuring Inflammation and Oxidative Stress Ex Vivo in Research and Clinical Practice-Which to Use Regarding Disease Outcomes?

Authors:  Alain Menzel; Hanen Samouda; Francois Dohet; Suva Loap; Mohammed S Ellulu; Torsten Bohn
Journal:  Antioxidants (Basel)       Date:  2021-03-09

7.  Paradoxical role of alveolar macrophage-derived granulocyte-macrophage colony-stimulating factor in pulmonary host defense post-bone marrow transplantation.

Authors:  Megan N Ballinger; Leah L N Hubbard; Tracy R McMillan; Galen B Toews; Marc Peters-Golden; Robert Paine; Bethany B Moore
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-05-02       Impact factor: 5.464

8.  Altered kinetics of interleukin-6 and other inflammatory mediators during exercise in children with type 1 diabetes.

Authors:  Jaime S Rosa; Stacy R Oliver; Masato Mitsuhashi; Rebecca L Flores; Andria M Pontello; Frank P Zaldivar; Pietro R Galassetti
Journal:  J Investig Med       Date:  2008-04       Impact factor: 2.895

Review 9.  CD4 T cells: Balancing the coming and going of autoimmune-mediated inflammation in the CNS.

Authors:  Bonnie N Dittel
Journal:  Brain Behav Immun       Date:  2008-01-18       Impact factor: 7.217

Review 10.  Novel GM-CSF-based vaccines: One small step in GM-CSF gene optimization, one giant leap for human vaccines.

Authors:  Ting-Wei Yu; Ho-Yen Chueh; Ching-Chou Tsai; Cheng-Tao Lin; Jiantai Timothy Qiu
Journal:  Hum Vaccin Immunother       Date:  2016-08-25       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.